values were defined as those values within 2 standard deviations from the control means from each age group.
Genetic studies
The incidence for the SCAs was set at 1 in 200,000. Twelve age-dependent liability classes of penetrance were assigned to at-risk currently unaffected individuals based on the age of onset of ataxia in the affected individuals of the pedigree. The classes of penetrance were constructed assuming a normal distribution of the age of onset, with a mean age of onset of μ = 48.36 years and a standard deviation σ = 9.89. A normal density function was constructed according to the normalized variable corresponding values (Z) from our data of age at onset (X) from the N = 10 affected individuals of the pedigree (Z = (X -μ) / σ). The penetrance value for each individual of the pedigree was calculated as the probability to be affected, given Kosambi map functions were used to transform the genetic distance to recombination fraction. 3 In the multipoint analysis, the multipoint P-value was obtained in a simulation analysis of the pedigree, with 1,000 replicates with the real phenotypic data and using pseudo-random genotype number assignment by the Monte Carlo method incorporated in the computer software SLINK (LSIM function), which calculated the P-value as the probability to obtain a LOD score equal or greater to the LOD score estimated in the observed data, assuming the hypotheses of no linkage (θ = 0.5) between the locus trait and the set of markers (null hypothesis, H0). For whole-exomic sequencing, DNAs were enriched using SureSelect All Human Exome v.2 (50 Mb) target enrichment technology according to the manufacturer's protocol (Agilent, CA). The enriched DNA was paired-end sequenced on an ABI SOLiD v4 (Life Technologies, CA). Reads were mapped against the reference human genome (UCSC hg19) with Bioscope v1.3 (solidsoftwaretools.com) using default parameters. Variant and indel calling were performed with a combination of the Genome Analysis Toolkit 4 and SAMtools v0.16. 5 Based on the hypothesis that the mutation underlying this rare familial disease was not present in the general population, known variants were discarded from further analysis based on the information from the Ensembl v62 database, which hosts data from the most important Human variation resources such as 1000 Genomes, dbSNP or HapMap among others. Then, variants not shared by both patients were filtered out. Synonymous changes were identified and filtered from the variant list using the CONsensus Deleteriousness score of missense SNVs (Condel) (bg.upf.edu/condel/analysis). 6 
